GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Taiwan Bio Therapeutics Co Ltd (ROCO:6892) » Definitions » PB Ratio

Taiwan Bio Therapeutics Co (ROCO:6892) PB Ratio : 3.84 (As of Jun. 05, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Taiwan Bio Therapeutics Co PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-06-05), Taiwan Bio Therapeutics Co's share price is NT$37.80. Taiwan Bio Therapeutics Co's Book Value per Share for the quarter that ended in Dec. 2023 was NT$9.85. Hence, Taiwan Bio Therapeutics Co's PB Ratio of today is 3.84.

The historical rank and industry rank for Taiwan Bio Therapeutics Co's PB Ratio or its related term are showing as below:

ROCO:6892' s PB Ratio Range Over the Past 10 Years
Min: 3.04   Med: 3.53   Max: 4.93
Current: 3.84

During the past 5 years, Taiwan Bio Therapeutics Co's highest PB Ratio was 4.93. The lowest was 3.04. And the median was 3.53.

ROCO:6892's PB Ratio is ranked worse than
67.12% of 1311 companies
in the Biotechnology industry
Industry Median: 2.55 vs ROCO:6892: 3.84

During the past 12 months, Taiwan Bio Therapeutics Co's average Book Value Per Share Growth Rate was 0.10% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 12.10% per year.

During the past 5 years, the highest 3-Year average Book Value Per Share Growth Rate of Taiwan Bio Therapeutics Co was 28.90% per year. The lowest was 12.10% per year. And the median was 20.50% per year.

Back to Basics: PB Ratio


Taiwan Bio Therapeutics Co PB Ratio Historical Data

The historical data trend for Taiwan Bio Therapeutics Co's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taiwan Bio Therapeutics Co PB Ratio Chart

Taiwan Bio Therapeutics Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
- - - 3.11 3.44

Taiwan Bio Therapeutics Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
PB Ratio Get a 7-Day Free Trial - - 3.11 3.32 3.44

Competitive Comparison of Taiwan Bio Therapeutics Co's PB Ratio

For the Biotechnology subindustry, Taiwan Bio Therapeutics Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Taiwan Bio Therapeutics Co's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Taiwan Bio Therapeutics Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Taiwan Bio Therapeutics Co's PB Ratio falls into.



Taiwan Bio Therapeutics Co PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Taiwan Bio Therapeutics Co's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=37.80/9.851
=3.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Taiwan Bio Therapeutics Co  (ROCO:6892) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Taiwan Bio Therapeutics Co PB Ratio Related Terms

Thank you for viewing the detailed overview of Taiwan Bio Therapeutics Co's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Taiwan Bio Therapeutics Co (ROCO:6892) Business Description

Traded in Other Exchanges
N/A
Address
No. 18, Lane 120, Hu Road, Section 1, 6th Floor, Neihu District, Taipei, TWN
Taiwan Bio Therapeutics Co Ltd is a regenerative medicine company specializing in the development of new cell medicines. It provides cell product process development and foundry (CDMO/CMO) services.

Taiwan Bio Therapeutics Co (ROCO:6892) Headlines

No Headlines